Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania

Bipolar Disorders

Volumn 5, Issue 1, 2003, Pages 1-5

  Chengappa, K N Roy ^a,b   Baker, Robert W ^c   Shao, Lixin ^c   Yatham, Lakshmi N ^d   Tohen, Mauricio ^c,e   Gershon, Samuel ^a   Kupfer, David J ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b Mayview State Hospital   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bipolar I disorder; Euthymia; Functional outcomes; Mania; Olanzapine; Placebo; Remission; Response

Indexed keywords

LORAZEPAM; OLANZAPINE; PLACEBO;

ADULT; ARTICLE; BIPOLAR MANIA; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MEDICAL LITERATURE; MONOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REMISSION; SHORT COURSE THERAPY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 0037648427     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5618.2003.02237.x     Document Type: Article

References (12)

1. Tohen M, Sanger TM, McElroy SL et al. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry 1999; 156: 702-709.
2. Tohen M, Jacobs TG, Grundy SL, et al. Efficacy of olanzapine in acute bipolar mania. A double-blind, placebo-controlled study. Arch Gen Psychiatry 2000; 57: 841-849.
3. Young RC, Briggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
4. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278-296.
5. Spearing MK, Post PM, Leverich GS, Brandt D, Nolen W. Modification of the clinical global impression (CGI) scale for use in bipolar illness (BP). The CGI-BP Psychiatr Res 1997; 73: 159-171.
6. Nierenberg AA, DeCecco LM. Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression. J Clin Psychiatry 2001; 62 (Suppl. 16): 5-9.
7. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders Patient Edition (SCID-I/P, Version 2.0). New York: New York State Psychiatric Institute, 1995.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington DC: American Psychiatric Association, 1994.
9. Tohen M, Hennen J, Zarate CM et al. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry 2000; 157: 220-228.
10. Kupfer DJ, Frank E, Grochocinski VJ et al. Stabilization in the treatment of mania, depression and mixed states. Acta Neuropsychiatrica 2000; 12: 110-114.
11. Angst J, Kupfer DJ, Rosenbaum JF. Recovery from depression: risk or reality? Acta Psychiatr Scand 1996; 93: 413-419.
12. Levine J, Chengappa KNR, Brar JS, Gershon S, Kupfer DJ. Illness characteristics and their association with prescription patterns for bipolar I disorder. Bipolar Disord 2001; 3: 41-49.